HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fani Kalala Selected Research

Hematologic Neoplasms (Hematological Malignancy)

1/2016Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein-Barr virus-positive patients with chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fani Kalala Research Topics

Disease

3COVID-19
12/2023 - 11/2022
3Neoplasms (Cancer)
01/2017 - 04/2008
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2017 - 01/2016
2B-Cell Lymphoma (Lymphoma, B Cell)
02/2014 - 12/2013
1Parkinson Disease (Parkinson's Disease)
02/2024
1Measles
07/2023
1Necrosis
12/2022
1Neuroinflammatory Diseases
12/2022
1Inflammation (Inflammations)
12/2022
1Cytopenia
08/2021
1Splenomegaly
08/2021
1Lymphoma (Lymphomas)
01/2016
1Hematologic Neoplasms (Hematological Malignancy)
01/2016
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2015
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2015
1Epstein-Barr Virus Infections
12/2013
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2013
1Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2013
1Systemic Mastocytosis
02/2009
1Carcinoma (Carcinomatosis)
11/2008
1Lung Neoplasms (Lung Cancer)
11/2008
1Mycoses (Diseases, Fungus)
05/2008
1Pneumonia (Pneumonitis)
05/2008
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2008
1Fibrosis (Cirrhosis)
11/2006
1Hepatitis
11/2006
1Hepatitis B
11/2006
1Chronic Hepatitis (Chronic Active Hepatitis)
11/2006
1Hepatitis C
11/2006
1Liver Diseases (Liver Disease)
11/2006

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
01/2017 - 11/2006
3Messenger RNA (mRNA)IBA
12/2023 - 11/2006
3Immunoglobulin G (IgG)IBA
12/2023 - 11/2022
2Immunoglobulin A (IgA)IBA
12/2023 - 11/2022
2Membrane Proteins (Integral Membrane Proteins)IBA
01/2016 - 02/2014
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
02/2014 - 11/2006
2SurvivinIBA
02/2014 - 11/2008
2Imatinib Mesylate (Gleevec)FDA Link
02/2009 - 05/2008
1sortilinIBA
02/2024
1Biomarkers (Surrogate Marker)IBA
02/2024
1mRNA VaccinesIBA
12/2023
1VaccinesIBA
12/2023
1AntibodiesIBA
07/2023
1Interleukin-18 (Interleukin 18)IBA
01/2023
1ChemokinesIBA
12/2022
1CytokinesIBA
12/2022
1STAT5 Transcription FactorIBA
01/2016
1Oncogene Proteins (Oncogene Protein)IBA
01/2016
1Azacitidine (5 Azacytidine)FDA Link
09/2015
1Rituximab (Mabthera)FDA Link
12/2013
1Peptides (Polypeptides)IBA
11/2008
1HLA-A24 AntigenIBA
11/2008
1Protein Isoforms (Isoforms)IBA
11/2006
1LeptinIBA
11/2006
1RNA IsoformsIBA
11/2006
1Leptin ReceptorsIBA
11/2006

Therapy/Procedure

1Adenoidectomy
08/2021
1Tonsillectomy
08/2021
1Immunotherapy
11/2008
1Therapeutics
05/2008